DR. I. Vanhoutte, radiotherapie-oncologie SRL
DR. I. Vanhoutte, radiotherapie-oncologie reported total assets of 768,759 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
By total assets for 2025, DR. I. Vanhoutte, radiotherapie-oncologie ranks among the 5,000 largest of the 15,444 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of DR. I. Vanhoutte, radiotherapie-oncologie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -96 % Total assets +34 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DR. I. Vanhoutte, radiotherapie-oncologie's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 713,360 € | ||||
| Equity | 18,550 € | ||||
| Cash | 168,044 € | ||||
| EBITDA | €1.06m | ||||
| Total assets | 768,759 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 09 Jul 2025
- Year ended 31 Dec 2023filed on 16 Jul 2024
- Year ended 31 Dec 2022filed on 28 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
DR. I. Vanhoutte, radiotherapie-oncologie's financial analysis
- Solvency2.4%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DR. I. Vanhoutte, radiotherapie-oncologie
1 active director(s) in the register.
DR. I. Vanhoutte, radiotherapie-oncologie's shareholders and holdings →DR. I. Vanhoutte, radiotherapie-oncologie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0683.757.552
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 26 Oct 2017
- Registered office
- 9000 Ghent
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
DR. I. Vanhoutte, radiotherapie-oncologie (SRL) has been based in Ghent since 2017, active in: medical specialists activities. For 2025, it reports a net profit of 713,360 € and equity of 18,550 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to DR. I. Vanhoutte, radiotherapie-oncologie
Companies in the same business, of comparable size and area, outside its group.
- LoMiXa Zonhoven · balance sheet 768,190 €
- Mullie Tine Orthopedische Heelkunde Medical specialists activities Kuurne · balance sheet 769,424 €
- M - Invest Wevelgem · balance sheet 768,064 €
- Delaere Vastgoed Service activities incidental to land transportation Jabbeke · balance sheet 769,893 €
- Tover Brussels · balance sheet 768,791 €
- Cabinet d'Imagerie Medicale G. Ponghis Neupré · balance sheet 768,531 €
- Assoc Grand Parc Charleroi · balance sheet 767,866 €
- Neoped Beersel · balance sheet 767,830 €
Frequently asked questions about DR. I. Vanhoutte, radiotherapie-oncologie
What is the revenue of DR. I. Vanhoutte, radiotherapie-oncologie?
DR. I. Vanhoutte, radiotherapie-oncologie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DR. I. Vanhoutte, radiotherapie-oncologie?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for DR. I. Vanhoutte, radiotherapie-oncologie. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0683757552. Its company number (CBE) is 0683.757.552.
Where is the registered office of DR. I. Vanhoutte, radiotherapie-oncologie?
According to the CBE register, the registered office of DR. I. Vanhoutte, radiotherapie-oncologie is in 9000 Ghent.
What is the equity of DR. I. Vanhoutte, radiotherapie-oncologie?
At the close of the 2025 financial year, the equity of DR. I. Vanhoutte, radiotherapie-oncologie amounts to 18,550 €, a solvency of 2.4% of total assets.
Who manages DR. I. Vanhoutte, radiotherapie-oncologie?
The register lists 1 active mandates at DR. I. Vanhoutte, radiotherapie-oncologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is DR. I. Vanhoutte, radiotherapie-oncologie within its sector?
By total assets for 2025, DR. I. Vanhoutte, radiotherapie-oncologie ranks among the 5,000 largest of the 15,444 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of DR. I. Vanhoutte, radiotherapie-oncologie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →